- Dummy
-
Dummy dummy dummy
dummy dummy.- Find out more
- At a Glance
-
Your health is
our specialty.- Find out more
- Sustainability
-
Our commitment to
grow and improve- Find out more
- History
-
From humble beginnings
to an industry leader- Find out more
- Our Business
-
What we do to
enrich people’s lives- Find out more
- Our Products
-
Our offerings for
all aspects of your life- Find out more
About Taisho Pharmaceutical Group
At a Glance
History
Our Business
Our Products
Corporate News
News
News
-
HoldingsJuly 1, 2024
Organization - Announcement of new structure
-
HoldingsJanuary 16, 2024
Finance - Notice Regarding the Results of the Tender Offer by Otemon Co., Ltd. for the Company Shares Etc. and Change of the Parent Company and the Largest Shareholder Among the Major Shareholders
-
Group CompanyJanuary 16, 2024
Products - Launch of Nanozora® 30mg Autoinjector for S.C. Injection
-
Group CompanyDecember 1, 2023
Products - Notification of the Approval of Home Self-injection Guidance and Management Fees and the Derestriction of the Dosing Period for NanozoraⓇ
-
Group CompanyAugust 1, 2023
R&D - Notification of Approval to Manufacture and Market Nanozora® 30mg Autoinjectors for S.C. Injection in Japan
Sustainability
Sustainability Policy
Environment
Social
Governance
- Find out more